Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

KongMode Feb. 14 at 11:59 PM

$CAPT $QNTM $EVAX $IBO <>~>~>

0 · Reply

FickleFin Feb. 13 at 11:56 AM

$QNTM $GNS ↘️📉

0 · Reply

EatingWithSpork Feb. 13 at 11:46 AM

$QNTM what’s going on here ST?

0 · Reply

NoFearHere Feb. 12 at 7:46 PM

$QNTM seems every consolidation leads to another drop

0 · Reply

ShadowSnake Feb. 12 at 7:45 PM

$QNTM I’d be absolutely surprised if Malone isn’t facing lawsuits right now 😳

0 · Reply

NoFearHere Feb. 12 at 7:44 PM

$QNTM they're inadequacies make one think they wont win in the lawsuit, and rather guilty

0 · Reply

ShadowSnake Feb. 12 at 7:44 PM

$QNTM $4 to $40 to $3.80 in a year 👀

0 · Reply

NoFearHere Feb. 12 at 7:43 PM

$QNTM It's very close to visiting ⤵️

0 · Reply

Redman70 Feb. 12 at 4:59 PM

$QNTM May be the worst management team on the Nasdaq. No updates on Unbuzzd. The management team over there looks to be just as bad as QNTM's management. No movement on the lawsuit. No support in the stock. Not looking out for shareholders -- at all. All around, a very poor situation.

0 · Reply

FickleFin Feb. 12 at 2:37 PM

$QNTM $GNS Desperado arent we?? @califinancialadvisor 🥴📉

1 · Reply

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 10, 2025, 8:00 PM EST - 2 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Nov 27, 2025, 4:00 PM EST - 2 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 26, 2025, 9:30 AM EST - 2 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 7, 2025, 7:00 AM EST - 3 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 3 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 3 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 4 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 20, 2025, 8:30 AM EDT - 4 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 4 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 4 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 4 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 8, 2025, 8:00 AM EDT - 4 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 4 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025, 7:00 AM EDT - 4 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 2, 2025, 7:57 AM EDT - 4 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 4 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 4 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 5 months ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 5 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 5 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 5 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 5 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 6 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 6 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 6 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 6 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 6 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 6 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 7 months ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 8 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 8 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 8 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 8 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 9 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 9 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 9 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 9 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 9 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 9 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 9 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 10 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 10 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 10 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 10 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

KongMode Feb. 14 at 11:59 PM

$CAPT $QNTM $EVAX $IBO <>~>~>

0 · Reply

FickleFin Feb. 13 at 11:56 AM

$QNTM $GNS ↘️📉

0 · Reply

EatingWithSpork Feb. 13 at 11:46 AM

$QNTM what’s going on here ST?

0 · Reply

NoFearHere Feb. 12 at 7:46 PM

$QNTM seems every consolidation leads to another drop

0 · Reply

ShadowSnake Feb. 12 at 7:45 PM

$QNTM I’d be absolutely surprised if Malone isn’t facing lawsuits right now 😳

0 · Reply

NoFearHere Feb. 12 at 7:44 PM

$QNTM they're inadequacies make one think they wont win in the lawsuit, and rather guilty

0 · Reply

ShadowSnake Feb. 12 at 7:44 PM

$QNTM $4 to $40 to $3.80 in a year 👀

0 · Reply

NoFearHere Feb. 12 at 7:43 PM

$QNTM It's very close to visiting ⤵️

0 · Reply

Redman70 Feb. 12 at 4:59 PM

0 · Reply

FickleFin Feb. 12 at 2:37 PM

$QNTM $GNS Desperado arent we?? @califinancialadvisor 🥴📉

1 · Reply

CryptoAlex1040 Feb. 12 at 2:34 PM

$GNS $QNTM We hate Malone … this is bullish. F that guy

1 · Reply

FickleFin Feb. 12 at 2:21 PM

$QNTM $GNS why would anyone invest at this point?? @califinancialadvisor, Zeeshan and Anthony led you all to the slaughter house... 🥴 📉 same degenerates pumping. This company isnt on your side. 😑

1 · Reply

FickleFin Feb. 10 at 1:15 PM

$QNTM someone trying to unload $200K worth.. dont get caught holding the bag. $GNS notice how all the spoofing allegations have become silent... SMART $$$ knows NOT TO INVEST in these 💩 companies.

1 · Reply

HermesHedges Feb. 9 at 3:50 PM

$QNTM Quantum or materials technology; pre-commercial with long timeline.

0 · Reply

CYoung787 Feb. 8 at 10:28 PM

$BINI $GNS $MMAT $QNTM Follow @Regardo to pick losing stocks and lose money. He's an expert at that.

0 · Reply

CYoung787 Feb. 8 at 4:57 PM

$BINI $GNS $MMAT $QNTM How come $BINI hasn't filed their 10-K annual report to the SEC yet? It was due at the end of 2025 and there is no extension filing and most importantly NO 10-K. Doesn't $BINI want to show their financials? Is $BINI just at that point that they don't care and won't do anything and let the company die without filing the REQUIRED reports with the SEC? You notice last year they finally reported on 1/24 after putting in a filing for inability to file on time in 12/30.

0 · Reply

CYoung787 Feb. 8 at 4:01 PM

$BINI $GNS $MMAT $QNTM So what's the latest in the case? It seems attorneys have left the case for $BINI. Why is that? How come there is no other developments in the case except for attorneys withdrawing?

1 · Reply

Regardo7epic Feb. 8 at 2:21 PM

$BINI $GNS $MMAT $BINI $QNTM

0 · Reply

HeWhoLaughs Feb. 6 at 6:50 PM

$BITF $LZ $SPY $GPUS $QNTM Market is going parabolic

0 · Reply

HeWhoLaughs Feb. 6 at 5:28 PM

$LZ $SPY That was foolish $QNTM

0 · Reply

HeWhoLaughs Feb. 6 at 5:15 PM

$BITF $LZ $SPY My bad I meant $QNTM $TSLA

0 · Reply

HeWhoLaughs Feb. 6 at 4:23 PM

$LZ $QNTM $SLV $SOL.X $SPY I’ll call you out buddy. I don’t like people who work in shadows… causes the samurai Saint to come out in me… he’s an angry man…

0 · Reply

Market Cap	13.89M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	21,100
Avg Vol	73,620
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	3%
Beta	0.30
Analysts	Sell
Price Target	$35.50